S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55

Avinger Stock Forecast, Price & News

+0.01 (+3.22%)
(As of 01/18/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
2.83 million shs
Average Volume
3.73 million shs
Market Capitalization
$30.68 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive AVGR News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

Avinger logo

About Avinger

Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.


See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$8.76 million
Book Value
$0.15 per share


Net Income
$-19.01 million
Net Margins
Pretax Margin




Free Float
Market Cap
$30.68 million
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

1.80 out of 5 stars

Medical Sector

845th out of 1,414 stocks

Surgical & Medical Instruments Industry

86th out of 130 stocks

Analyst Opinion: 3.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Avinger (NASDAQ:AVGR) Frequently Asked Questions

Is Avinger a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Avinger stock.
View analyst ratings for Avinger
or view top-rated stocks.

How has Avinger's stock price been impacted by COVID-19 (Coronavirus)?

Avinger's stock was trading at $0.43 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AVGR stock has decreased by 25.3% and is now trading at $0.3210.
View which stocks have been most impacted by COVID-19

Are investors shorting Avinger?

Avinger saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 789,600 shares, an increase of 26.2% from the December 15th total of 625,600 shares. Based on an average daily volume of 1,800,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.8% of the shares of the company are sold short.
View Avinger's Short Interest

When is Avinger's next earnings date?

Avinger is scheduled to release its next quarterly earnings announcement on Thursday, March 10th 2022.
View our earnings forecast for Avinger

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) issued its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The medical device company had revenue of $2.37 million for the quarter, compared to the consensus estimate of $2.52 million. Avinger had a negative trailing twelve-month return on equity of 109.27% and a negative net margin of 162.98%. During the same quarter in the previous year, the company earned ($0.08) EPS.
View Avinger's earnings history

When did Avinger's stock split? How did Avinger's stock split work?

Avinger's stock reverse split before market open on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for AVGR?

2 equities research analysts have issued 1-year price objectives for Avinger's stock. Their forecasts range from $2.00 to $2.50. On average, they anticipate Avinger's stock price to reach $2.25 in the next year. This suggests a possible upside of 600.9% from the stock's current price.
View analysts' price targets for Avinger
or view top-rated stocks among Wall Street analysts.

Who are Avinger's key executives?

Avinger's management team includes the following people:
  • Jeffrey M. Soinski, President, Chief Executive Officer & Director
  • Mark B. Weinswig, Chief Financial Officer
  • Himanshu N. Patel, Chief Technology Officer
  • Jaafer Golzar, Chief Medical Officer
  • Philip R. Preuss, Vice President-Marketing & Business Operations

What other stocks do shareholders of Avinger own?

When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

How do I buy shares of Avinger?

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.32.

How much money does Avinger make?

Avinger has a market capitalization of $30.68 million and generates $8.76 million in revenue each year. The medical device company earns $-19.01 million in net income (profit) each year or ($0.24) on an earnings per share basis.

How many employees does Avinger have?

Avinger employs 72 workers across the globe.

What is Avinger's official website?

The official website for Avinger is www.avinger.com.

Where are Avinger's headquarters?

Avinger is headquartered at 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at (650) 241-7900, via email at [email protected], or via fax at 800-229-2696.

This page was last updated on 1/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.